CPIG
Chicago Partners Investment Group Portfolio holdings
AUM
$3.47B
This Quarter Return
-2.26%
1 Year Return
+16.46%
3 Year Return
+59.01%
5 Year Return
+97.48%
10 Year Return
+126.98%
AUM
$1.85B
AUM Growth
+$1.85B
(-3.6%)
Cap. Flow
+$67.6M
Cap. Flow
% of AUM
3.65%
Top 10 Holdings %
Top 10 Hldgs %
24.59%
Holding
713
New
30
Increased
369
Reduced
198
Closed
56
Top Buys
| 1 |
Oneok
OKE
|
$11.7M |
| 2 |
Accenture
ACN
|
$9.36M |
| 3 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
$7.84M |
| 4 |
Dimensional Ultrashort Fixed Income ETF
DUSB
|
$7.17M |
| 5 |
Strive Emerging Markets ex-China ETF
STXE
|
$6.94M |
Top Sells
Sector Composition
| 1 | Energy | 9.83% |
| 2 | Financials | 8.25% |
| 3 | Technology | 7.35% |
| 4 | Healthcare | 2.47% |
| 5 | Consumer Discretionary | 1.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVN
626
Eaton Vance Municipal Income Trust
EVN
$414M
| $163K | 0.01% |
18,784
+8,550
| +84% | +$74.4K |
|
627
Ford
F
$46.2B
| $162K | 0.01% |
14,107
-2,351
| -14% | -$27K |
|
628
Uranium Energy
UEC
$5.11B
| $162K | 0.01% |
28,801
+9,844
| +52% | +$55.2K |
|
|
SLCA
629
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $158K | 0.01% |
12,127
| – | – |
|
630
Calamos Strategic Total Return Fund
CSQ
$2.97B
| $141K | 0.01% |
10,668
+121
| +1% | +$1.6K |
|
631
Open Lending Corp
LPRO
$268M
| $127K | 0.01% |
20,000
| – | – |
|
632
American Airlines Group
AAL
$8.87B
| $119K | 0.01% |
10,547
-147
| -1% | -$1.66K |
|
633
SCYNEXIS
SCYX
$35.2M
| $91.7K | ﹤0.01% |
53,321
+12,492
| +31% | +$21.5K |
|
|
MFM
634
MFS Municipal Income Trust
MFM
$212M
| $88.9K | ﹤0.01% |
20,021
+146
| +0.7% | +$648 |
|
635
89bio
ETNB
$1.37B
| $71.4K | ﹤0.01% |
10,715
+466
| +5% | +$3.1K |
|
636
Cytosorbents Corp
CTSO
$61.5M
| $67.4K | ﹤0.01% |
36,358
+16,598
| +84% | +$30.8K |
|
637
Iovance Biotherapeutics
IOVA
$800M
| $61.7K | ﹤0.01% |
17,871
+5,000
| +39% | +$17.3K |
|
638
Wave Life Sciences
WVE
$1.27B
| $59.9K | ﹤0.01% |
11,136
-7,663
| -41% | -$41.2K |
|
639
CureVac
CVAC
$1.21B
| $59.4K | ﹤0.01% |
+10,855
| New | +$59.4K |
|
|
GLO
640
Clough Global Opportunities Fund
GLO
$238M
| $54.3K | ﹤0.01% |
12,861
-28,124
| -69% | -$119K |
|
641
Alpha Tau Medical Warrant
DRTSW
$6.68M
| $52.9K | ﹤0.01% |
203,324
| – | – |
|
642
Geron
GERN
$893M
| $52.9K | ﹤0.01% |
29,866
+8,557
| +40% | +$15.1K |
|
643
W&T Offshore
WTI
$263M
| $50.6K | ﹤0.01% |
12,462
-2,974
| -19% | -$12.1K |
|
644
Acumen Pharmaceuticals
ABOS
$84.2M
| $44.9K | ﹤0.01% |
+13,579
| New | +$44.9K |
|
645
Vor Biopharma
VOR
$253M
| $37.4K | ﹤0.01% |
17,996
-7,069
| -28% | -$14.7K |
|
|
CLYM
646
Climb Bio, Inc. Common Stock
CLYM
$165M
| $32.8K | ﹤0.01% |
12,806
-3,764
| -23% | -$9.64K |
|
647
Esperion Therapeutics
ESPR
$490M
| $23.5K | ﹤0.01% |
+29,499
| New | +$23.5K |
|
|
CBIO
648
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
| $23.4K | ﹤0.01% |
20,000
| – | – |
|
649
Lumen
LUMN
$4.84B
| $21K | ﹤0.01% |
16,169
+815
| +5% | +$1.06K |
|
650
Barnes & Noble Education
BNED
$283M
| $18.1K | ﹤0.01% |
18,707
| – | – |
|